MNL vs. GSS, HRI, BPCR, AGT, JPE, BBGI, JFJ, BRWM, TRY, and CGT
Should you be buying Manchester & London stock or one of its competitors? The main competitors of Manchester & London include Genesis Emerging Markets Fund (GSS), Herald (HRI), BioPharma Credit (BPCR), AVI Global Trust (AGT), JPMorgan Elect plc - Managed Growth (JPE), BBGI Global Infrastructure (BBGI), JPMorgan Japanese (JFJ), BlackRock World Mining Trust (BRWM), TR Property Investment Trust (TRY), and Capital Gearing (CGT). These companies are all part of the "asset management" industry.
Manchester & London vs.
Genesis Emerging Markets Fund (LON:GSS) and Manchester & London (LON:MNL) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations and institutional ownership.
Manchester & London has a net margin of 95.89% compared to Genesis Emerging Markets Fund's net margin of 0.00%. Manchester & London's return on equity of 39.92% beat Genesis Emerging Markets Fund's return on equity.
Genesis Emerging Markets Fund pays an annual dividend of GBX 0.17 per share. Manchester & London pays an annual dividend of GBX 14 per share and has a dividend yield of 2.2%. Genesis Emerging Markets Fund pays out 0.1% of its earnings in the form of a dividend. Manchester & London pays out 4.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
In the previous week, Manchester & London had 1 more articles in the media than Genesis Emerging Markets Fund. MarketBeat recorded 1 mentions for Manchester & London and 0 mentions for Genesis Emerging Markets Fund. Manchester & London's average media sentiment score of 1.84 beat Genesis Emerging Markets Fund's score of 0.00 indicating that Manchester & London is being referred to more favorably in the news media.
Manchester & London has lower revenue, but higher earnings than Genesis Emerging Markets Fund. Genesis Emerging Markets Fund is trading at a lower price-to-earnings ratio than Manchester & London, indicating that it is currently the more affordable of the two stocks.
Manchester & London received 15 more outperform votes than Genesis Emerging Markets Fund when rated by MarketBeat users. Likewise, 68.75% of users gave Manchester & London an outperform vote while only 62.00% of users gave Genesis Emerging Markets Fund an outperform vote.
59.7% of Manchester & London shares are owned by institutional investors. 2.1% of Manchester & London shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Manchester & London beats Genesis Emerging Markets Fund on 11 of the 14 factors compared between the two stocks.
Get Manchester & London News Delivered to You Automatically
Sign up to receive the latest news and ratings for MNL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Manchester & London Competitors List
Related Companies and Tools
This page (LON:MNL) was last updated on 3/28/2025 by MarketBeat.com Staff
Buy MNL Stock Free MNL Stock Alerts